Key Drivers
- Strong Cash Flow
- Solid Liquidity
- Premium Valuation
AIAI Summary
MMSI's investment case has shifted to proving that high-single-digit organic growth and margin expansion can convert into durable cash flow, as its premium ~34x earnings valuation leaves little room for working-capital deterioration, acquisition missteps, or slower deleveraging.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Solid Liquidity
- •Premium Valuation
MMSI combines strong margins, cash flow, and liquidity with manageable leverage, but its premium valuation and rising working capital warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support testing
- •Weak momentum
MMSI is in a short-term downtrend over the last month, with $85.0–$85.4 support at risk unless it reclaims $87.0–$87.4 resistance.
Declined 5.4% from the late-August high
Sentiment & News
Key News Insights:
- •Raised Outlook
- •Institutional Buying
- •Tariff Risks
Merit Medical's stronger results, raised outlook, product expansion, and institutional buying support momentum, though elevated valuation, tariffs, China exposure, and competition remain key execution risks.
The news is broadly positive for Merit Medical, but sustained upside depends on managing valuation and trade-related pressures
Similar Companies in Healthcare
Other companies in the same sector with AI ratings